Business Model & Revenue
BellRing is a pure-play proactive wellness holding company spun off from Post Holdings in 2022, running two scaled brands: Premier Protein — one of the top-selling ready-to-drink protein shake franchises in U.S. measured channels, extended into powders and bars — and Dymatize, a premium sports-nutrition powder business anchored by the ISO100 whey isolate line. FY26 net sales of $2.4 billion split overwhelmingly toward shakes, with Dymatize the faster grower (+10.7%) on international expansion and price realization.
The economics are branded consumer staples: BellRing designs and markets, buys manufacturing scale through co-manufacturing relationships (Post remains a strategic manufacturing partner), and sells through club, mass, grocery, convenience, e-commerce and Amazon channels. Historically that produced mid-30s gross margins and 20%+ EBITDA margins — a spread of brand equity over dairy-based input costs. FY26 broke the model's arithmetic: input inflation including tariffs, freight, and — decisively — an 8.1% negative price/mix in Q4 as promotions funded distribution and volume growth, compressed adjusted gross margin to 24.7% for the year and 20.1% in Q4.
Management's FY27 plan is a classic margin-repair playbook: $37 million of inventory actions annualizing, cost savings under new CEO Michael Axelrod (a Post veteran who took over in 2026), sharper promotional discipline, and Dymatize international strength carrying mix. The balance sheet reflects a company that leaned on leverage and buybacks in the good years — shares outstanding are down 7.9% in a year, but equity is negative and a revolver funds working capital seasonality. Cash generation, not EPS, is the metric to watch: $126 million of FY26 operating cash flow against $80 million of interest is a thin cushion if margins stay compressed.
Financial Highlights
Fiscal Year 2026 vs 2025 (year ended September 30)
| Metric | FY2026 | FY2025 | YoY |
|---|---|---|---|
| Net sales | $2,398.4M | $2,316.6M | +3.5% |
| Gross profit | $638.1M (26.6%) | $770.4M (33.3%) | -17.2% |
| Adjusted gross margin | 24.7% | 33.9% | -920 bps |
| Operating profit | $277.7M | $357.4M | -22.3% |
| Net earnings | $147.4M | $216.2M | -31.8% |
| Diluted EPS | $1.25 | $1.68 | -25.6% |
| Adjusted diluted EPS | $1.04 | $2.17 | -52.1% |
| Adjusted EBITDA | $288.8M | $481.6M | -40.1% |
| Cash and equivalents | $20.1M | $71.8M | -72.0% |
FY26 results absorbed a $37 million pre-tax inventory headwind (≈150 bps of gross margin), input-cost inflation including tariffs, and higher freight; FY25 SG&A carried a $69.0 million legal provision.
Quarterly Progression (fiscal 2026)
| Quarter | Revenue | Net Income | Diluted EPS | Gross Margin |
|---|---|---|---|---|
| Q1 (Dec '25) | $537.3M | $43.7M | $0.36 | 29.9% |
| Q2 (Mar '26) | $598.7M | $33.9M | $0.29 | 27.0% |
| Q3 (Jun '26) | $570.4M | $34.2M | $0.29 | 28.6% |
| Q4 (Sep '26) | $692.0M | $35.6M | $0.31 | 22.0% |
Q4 Beat/Miss vs Consensus
| Metric | Reported | Consensus | Delta |
|---|---|---|---|
| Net sales | $692.0M | $658.2M | +5.1% |
| Adjusted EPS | $0.22 | $0.23 | -1 cent |
| Adjusted EBITDA | $66.4M | $65.7M | +1.1% |
Balance Sheet Snapshot (Sep 30, 2026 unless noted)
| Item | Amount |
|---|---|
| Cash and equivalents | $20.1M |
| Inventories | $324.5M |
| Total assets | $846.1M |
| Long-term debt (Jun '26 quarter-end) | ≈$1,135M |
| Stockholders' equity (Jun '26) | negative ≈$467M |
| Weighted-average diluted shares | 116.5M (down 7.9% YoY) |
| FY26 operating cash flow | $126.0M |
| FY26 interest expense, net | $80.0M |
Guidance: FY2027 net sales of $2.32-2.42 billion; Adjusted EBITDA of $310-350 million; refreshed long-term financial targets promised on the Q2 FY27 earnings call.
Competitive Landscape
BellRing competes in the U.S. protein RTD and powder categories, where it holds leading measured-channel share in shakes but faces the most aggressive competitive backdrop since the category's inception — premium dairy capacity coming online, private-label pressure, and GLP-1-era questions about caloric beverage demand.
- Fairlife / Core Power (Coca-Cola): The structural share threat. Coca-Cola's ultra-filtered milk capacity and Core Power's shelf-stable and refrigerated distribution muscle put the industry's best distribution system directly behind a competing protein shake — the main reason BellRing's price/mix has gone deeply negative defending shelf space.
- Simply Good Foods (SMPL) / Quest: Public comp in active nutrition; Quest bars and shakes plus Atkins give it scale in snacking adjacencies, and its balance sheet carries a fraction of BellRing's leverage — the market prices SMPL at a meaningful premium for that reason.
- Glanbia (Optimum Nutrition / Gold Standard): Global leader in protein powder, competing head-on with Dymatize's ISO100; Glanbia's scale in whey sourcing is a structural input-cost advantage BellRing cannot replicate.
- Hormel / Muscle Milk (CytoSport): The faded legacy shake brand — a cautionary precedent for how quickly RTD share can decay once promotional intensity and innovation slip.
- Private label (Costco Kirkland Signature, retailer brands): In an inflation cycle, the fastest-growing competitor at the price tier where Premier's promotions now position it.
Moats:
- Brand equity: Premier Protein remains a top U.S. RTD protein shake brand by dollar share despite two years of share defense — 8.8% consumption growth in the latest quarter says the franchise is not eroding
- Scale economics: $2.4 billion of revenue buys dairy-protein sourcing and co-manufacturing capacity that sub-scale challengers cannot access
- Distribution breadth across club, mass, convenience and Amazon — a shelf-presence moat measured in years of buyer relationships
- The Post relationship: co-manufacturing and shared services lower fixed costs relative to a standalone equivalent
Catalysts
-
Refreshed strategy and long-term financial targets — Q2 FY27 call (spring 2027): Management committed on Wednesday to publish new long-term targets; this is the single event that could re-anchor the multiple, and it comes with one quarter of Axelrod-era execution in hand
-
Q1 FY27 earnings (February 2027): First clean read on gross margin ex-inventory-actions; consensus will look for the 24-25% adjusted gross margin floor holding and EBITDA cadence toward the $310-350 million guide
-
Cost-savings program traction: FY27 EBITDA guidance implies ≈14% growth at midpoint on ≈1.5% sales growth — the spread must come from procurement, trade-spend discipline and logistics; any quantified savings figure moves estimates
-
Tariff and dairy input-cost relief: FY26 margin absorbed tariff-inclusive input inflation; each quarter without new cost escalation mechanically helps the year-over-year compare through FY27
-
Capital allocation pivot: With buybacks shrinking the count 7.9% a year but quick ratio at 0.77 and cash at $20.1 million, a pivot from repurchases toward deleveraging would signal margin-repair conviction — and improve the equity story more than another 1% of share count reduction
Key Risks
- Margin structure — adjusted gross margin fell from 33.9% to 24.7% in one year and Q4 printed 20.1%; if promotional intensity defending shelf space against Fairlife/Core Power is structural rather than cyclical, FY27 EBITDA guidance is a ceiling, not a floor
- Leverage — ≈$1.1 billion of net debt, $80 million of net interest against $126 million of operating cash flow, negative equity and a 0.77 quick ratio leave no room for a second down-year in earnings
- GLP-1 demand erosion — appetite-suppressing drug adoption directly questions caloric RTD shake volumes; FY27 sales guidance of -0.5% to +3.5% already concedes flat demand
- Input costs and tariffs — FY26 margin compression was materially driven by tariff-inclusive input inflation and freight; escalation re-runs the FY26 margin squeeze before cost savings arrive
- Customer and channel concentration — club and mass retailers hold pricing power in a promotional cycle, and inventory destocking at any top customer amplifies the negative price/mix already running at -8.1% in Q4
Our Thesis
BellRing is a genuine fallen angel: a 12.9% three-year revenue CAGR and the strongest RTD shake brand in America, repriced from a staples darling to a leveraged turnaround after Adjusted EBITDA fell 40% in FY26 and adjusted EPS halved from $2.17 to $1.04. Wednesday's print shows the demand engine never broke — volume grew 14.9% in Q4 and Dymatize consumption rose 12.1% — but the P&L did: price/mix ran at negative 8.1% as management bought distribution with promotions, while tariffs, dairy input costs and freight compressed adjusted gross margin by 960 basis points. New CEO Michael Axelrod, 100 days into the job, is promising cost savings, a refreshed strategy, and long-term targets on the Q2 FY27 call. The market re-rated the stock 16.5% for that promise before a single quarter of proof.
Our $13.50 target applies 8x to the $330 million FY27 EBITDA guidance midpoint, subtracts ≈$1.12 billion of net debt, and divides by 116.3 million shares — roughly where the stock opened, which is the point. The optimistic path (margin inflection to 9x on $330 million) reaches ≈$15.90; the bear path (guide-down to $300 million at 6.5x) implies ≈$7.20. With FY27 revenue guided to -0.5% to +3.5%, interest expense at $80 million against $126 million of operating cash flow, and a quick ratio of 0.77, the risk/reward is balanced, not asymmetric. Wait for the margin proof; the entry is no longer free.
Get reports like this delivered free
New small-cap research every week. No paywall, no fluff.